Opioid Use Disorder

Eat, Sleep, Console: Reducing NICU Admissions of Infants With Prenatal Opioid Exposure
Eat, Sleep, Console: Reducing NICU Admissions of Infants With Prenatal Opioid Exposure 1024 575 Lauren Dembeck

Focusing on non-pharmacological care, emphasizing mother-baby bonding, and natural infant behaviors may keep infants out of the NICU, but other barriers may limit implementation. Infants exposed to opioids in utero may experience withdrawal symptoms after birth, which can vary in severity depending on many factors, such as length of exposure and type of opioid. In…

Treatment for Substance Use Disorder in the Synthetic Opioid Era
Treatment for Substance Use Disorder in the Synthetic Opioid Era 1024 683 Alaina Doklovic

Medications for opioid use disorder (MOUD) is the recommended first line treatment for adolescents with opioid use disorder (OUD), the chronic use of opioids and/or synthetic opioids that causes clinically significant distress or impairment. Buprenorphine is the most accessible medication for MOUD. Studies show long-term use of buprenorphine decreases opioid use, reduces overdose risk and…

Trauma and Resilience in Youth With Opioid Use and Eating Disorders
Trauma and Resilience in Youth With Opioid Use and Eating Disorders 1024 575 Pam Georgiana
Teen girl with backpack

Health care providers should expect patients to have hidden traumas and reduced resilience.   When treating adolescents and young adults in the Substance Use Treatment and Recovery program at Nationwide Children’s, medical director Erin R. McKnight, MD, MPH, noticed that while most of her young patients had experienced some trauma in their lives, some patients…